Скачать или смотреть FY2024 | Your Support and How it Was Used | Bioinformatics Bootcamp

Welcome to the Cancer Research Institute's (CRI) Fiscal Year 2024 Impact Report and Video Series! This four-part series highlights CRI’s critical investments in groundbreaking cancer research and immunotherapy advances. You’ll see how our strategy of People X Biology X Data is driving progress in cancer research, as we work toward building a world immune to cancer.

Our first video offers a glimpse into CRI's inaugural Bioinformatics Bootcamp, which we launched to address the urgent need to equip scientists with data science expertise to advance cancer immunotherapy. Forty-four Postdoctoral Fellows gained hands-on training, bridging the gap between immunology and data-driven insights. This innovative program empowers scientists to drive breakthroughs in cancer treatment.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.